Izervay

Astellas' Izervay Shows Prolonged Efficacy in 2-Year Study for Geographic Atrophy Treatment

Astellas’ Izervay Shows Prolonged Efficacy in 2-Year Study for Geographic Atrophy Treatment

Anika Sharma

Astellas made a significant acquisition of Iveric Bio earlier this year, primarily motivated by the potential of Iveric’s geographic atrophy ...

astellas, izervay, geographic atrophy, eye disease, phase 3 trial, primary endpoint, dry AMD

Astellas claims positive results for Izervay in geographic atrophy but remains vague on data

Anika Sharma

Astellas, having recently secured FDA approval for its drug Izervay to treat geographic atrophy (GA), is now in direct competition ...

IZERVAY: FDA Approves First Drug for Geographic Atrophy

FDA Approves Izervay for Geographic Atrophy

SG Tylor

Source – Astellas Pharma Astellas Pharma has received FDA approval for Izervay (avacincaptad pegol intravitreal solution) for the treatment of geographic ...